Epigenetics in mental illness: Hope or hype?

Journal of Psychiatry and Neuroscience

Volumn 35, Issue 6, 2010, Pages 366-368

  Albert, Paul R ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VASOPRESSIN;

DISEASE PREDISPOSITION; DNA METHYLATION; DNA MODIFICATION; DNA SEQUENCE; EDITORIAL; ENVIRONMENTAL STRESS; EPIGENETICS; GENETIC RISK; HUMAN; INHERITANCE; MENTAL DISEASE; NONHUMAN; PHENOTYPE; RISK FACTOR;

EID: 78049289076     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.100148     Document Type: Editorial

References (23)

1. Weaver IC, Cervoni N, Champagne FA, et al. Epigenetic programming by maternal behavior. Nat Neurosci 2004; 7:847-54.
2. Colvis CM, Pollock JD, Goodman RH, et al. Epigenetic mechanisms and gene networks in the nervous system. J Neurosci 2005; 25:10379-89.
3. Abdolmaleky HM, Smith CL, Faraone SV, et al. Methylomics in psychiatry: modulation of gene-environment interactions may be through DNA methylation. Am J Med Genet B Neuropsychiatr Genet 2004; 127:51-9.
4. Madhani HD, Francis NJ, Kingston RE, et al. Epigenomics: A roadmap, but to where? Science 2008; 322:43-4.
5. Fuks F. DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev 2005; 15:490-5.
6. Prokhortchouk E, Defossez PA. The cell biology of DNA methylation in mammals. Biochim Biophys Acta 2008; 1783:2167-73.
7. Dulac C. Brain function and chromatin plasticity. Nature 2010; 465:728-35.
8. Time for the epigenome. Nature 2010; 464:487.
9. Ptashne M, Hobert O, Davidson E. Questions over the scientific basis of epigenome project. Nature 2010; 464:487.
10. Dermitzakis ET, Clark AG. Genetics. Life after GWA studies. Science 2009; 326:239-40.
11. Cichon S, Craddock N, Daly M, et al. Genomewide association studies: history, rationale, and prospects for psychiatric disorders. Am J Psychiatry 2009; 166:540-56.
12. Schwartz S, Susser E. Genome-wide association studies: Does only size matter? Am J Psychiatry 2010; 167:741-4.
13. Maunakea AK, Nagarajan RP, Bilenky M, et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 2010; 466:253-7.
14. Maze I, Covington HE 3rd, Dietz DM, et al. Essential role of the his tone methyltransferase G9a in cocaine-induced plasticity. Science 2010; 327:213-6.
15. Tremolizzo L, Carboni G, Ruzicka WB, et al. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc Natl Acad Sci U S A 2002; 99: 17095-100.
16. Grayson DR, Jia X, Chen Y, et al. Reelin promoter hypermethylation in schizophrenia. Proc Natl Acad Sci U S A 2005; 102:9341-6.
17. Murgatroyd C, Patchev AV, Wu Y, et al. Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat Neurosci 2009; 12:1559-66.
18. McGowan PO, Sasaki A, D'Alessio AC, et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 2009; 12:342-8.
19. Zhang TY, Meaney MJ. Epigenetics and the environmental regulation of the genome and its function. Annu Rev Psychol 2010; 61:439-66, C1-3.
20. Szyf M. Epigenetics, DNA methylation, and chromatin modifying drugs. Annu Rev Pharmacol Toxicol 2009; 49:243-63.
21. Covington HE 3rd, Maze I, LaPlant QC, et al. Antidepressant actions of histone deacetylase inhibitors. J Neurosci 2009; 29:11451-60.
22. Grayson DR, Kundakovic M, Sharma RP. Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders? Mol Pharmacol 2010; 77:126-35.
23. McGowan PO, Szyf M. The epigenetics of social adversity in early life: implications for mental health outcomes. Neurobiol Dis 2010; 39:66-72.